June 27, 2016 / 11:32 AM / in a year

BRIEF-Janssen inc- Health Canada has approved Invega Trinza 

June 27 (Reuters) - Janssen Inc

* Health Canada has approved Invega Trinza  (paliperidone palmitate), an antipsychotic medication for schizophrenia

* Health Canada’s approval of Invega Trinza  is based on two randomized, double-blind trials

* Invega Trinza provides a new dosing regimen option administered only four times a year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below